321 related articles for article (PubMed ID: 17907151)
21. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of topoisomerase-1-specific CD8+ T-cell response in systemic sclerosis.
Boin F; Wigley FM; Schneck JP; Oelke M; Rosen A
Ann N Y Acad Sci; 2005 Dec; 1062():137-45. PubMed ID: 16461796
[TBL] [Abstract][Full Text] [Related]
23. T cell repertoire in patients with stable scleroderma.
Tiev KP; Abriol J; Burland MC; Antonelli D; Klatzmann D; Cabane J; Boyer O
Clin Exp Immunol; 2005 Feb; 139(2):348-54. PubMed ID: 15654834
[TBL] [Abstract][Full Text] [Related]
24. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
[TBL] [Abstract][Full Text] [Related]
25. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
Kao JK; Hsue YT; Lin CY
J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
[TBL] [Abstract][Full Text] [Related]
27. Clonal T-cell populations are frequent in the skin and blood of patients with systemic sclerosis.
Kreuter A; Höxtermann S; Tigges C; Hahn SA; Altmeyer P; Gambichler T
Br J Dermatol; 2009 Oct; 161(4):785-90. PubMed ID: 19523172
[TBL] [Abstract][Full Text] [Related]
28. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.
Kuwana M; Feghali CA; Medsger TA; Wright TM
Arthritis Rheum; 2001 Jul; 44(7):1654-9. PubMed ID: 11465716
[TBL] [Abstract][Full Text] [Related]
29. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells.
Van Coppernolle S; Verstichel G; Timmermans F; Velghe I; Vermijlen D; De Smedt M; Leclercq G; Plum J; Taghon T; Vandekerckhove B; Kerre T
J Immunol; 2009 Oct; 183(8):4859-70. PubMed ID: 19801512
[TBL] [Abstract][Full Text] [Related]
30. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.
Mavalia C; Scaletti C; Romagnani P; Carossino AM; Pignone A; Emmi L; Pupilli C; Pizzolo G; Maggi E; Romagnani S
Am J Pathol; 1997 Dec; 151(6):1751-8. PubMed ID: 9403725
[TBL] [Abstract][Full Text] [Related]
31. Increased IL-4+ CD8+ T cells in peripheral blood and autoreactive CD8+ T cell lines of patients with inflammatory arthritis.
Baek HJ; Zhang L; Jarvis LB; Gaston JS
Rheumatology (Oxford); 2008 Jun; 47(6):795-803. PubMed ID: 18390584
[TBL] [Abstract][Full Text] [Related]
32. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells.
Distler JH; Jüngel A; Caretto D; Schulze-Horsel U; Kowal-Bielecka O; Gay RE; Michel BA; Müller-Ladner U; Kalden JR; Gay S; Distler O
Arthritis Rheum; 2006 Jan; 54(1):214-25. PubMed ID: 16385517
[TBL] [Abstract][Full Text] [Related]
33. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
Mitsuo A; Morimoto S; Nakiri Y; Suzuki J; Kaneko H; Tokano Y; Tsuda H; Takasaki Y; Hashimoto H
Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
[TBL] [Abstract][Full Text] [Related]
34. Influence of psoriatic peripheral blood CD4+ T and CD8+ T lymphocytes on C-myc, Bcl-xL and Ki67 gene expression in keratinocytes.
Li X; Fan X; Zhang K; Yin G; Liu Y
Eur J Dermatol; 2007; 17(5):392-6. PubMed ID: 17673382
[TBL] [Abstract][Full Text] [Related]
35. The immunobiology of systemic sclerosis.
Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
[TBL] [Abstract][Full Text] [Related]
36. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts.
Fukasawa C; Kawaguchi Y; Harigai M; Sugiura T; Takagi K; Kawamoto M; Hara M; Kamatani N
Eur J Immunol; 2003 Oct; 33(10):2792-800. PubMed ID: 14515263
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement.
Truchetet ME; Brembilla NC; Montanari E; Lonati P; Raschi E; Zeni S; Fontao L; Meroni PL; Chizzolini C
Arthritis Rheum; 2013 May; 65(5):1347-56. PubMed ID: 23335253
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients.
Luzina IG; Atamas SP; Wise R; Wigley FM; Choi J; Xiao HQ; White B
Arthritis Rheum; 2003 Aug; 48(8):2262-74. PubMed ID: 12905481
[TBL] [Abstract][Full Text] [Related]
39. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
[TBL] [Abstract][Full Text] [Related]
40. Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution.
Laplaud DA; Ruiz C; Wiertlewski S; Brouard S; Berthelot L; Guillet M; Melchior B; Degauque N; Edan G; Brachet P; Damier P; Soulillou JP
Brain; 2004 May; 127(Pt 5):981-95. PubMed ID: 14985265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
